RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial).

Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial).

Add to Collection
2020 Nov RCTs MS Kuchay, S Krishan, SK Mishra, NS Choudhary… - Diabetologia, 2020 - Springer

Full Author : ['Kuchay, Mohammad S', 'Krishan, Sonal', 'Mishra, Sunil K', 'Choudhary, Narendra S', 'Singh, Manish K', 'Wasir, Jasjeet S', 'Kaur, Parjeet', 'Gill, Harmandeep K', 'Bano, Tarannum', 'Farooqui, Khalid J', 'Mithal, Ambrish']
Journal Title : Diabetologia
Chapter : Section2, Section3, Section5
Journal Year : 2020
Cited by : 112

AIMS/HYPOTHESIS: Liraglutide, a daily injectable glucagon-like peptide-1 receptor (GLP-1r) agonist, has been shown to reduce liver fat content (LFC) in humans. Data regarding the effect of dulaglutide, a once-weekly GLP-1r agonist, on human LFC are scarce..... Read More

Keywords : ['nafld randomise control trial dlift trial', 'type diabetes', 'liver fat', 'patient', 'effect', 'dulaglutide']
PubMed Link : https://link.springer.com/article/10.1007/s00125-020-05265-7
Google Scholar Link : https://scholar.google.com/scholar?cites=5083674557966171759&as_sdt=2005&sciodt=0,5&hl=en&num=20